|
|
| E-191 / WuXi AppTec, Guangdong Zhongsheng Pharma (0 Trials) |
|
| E-434 / Palleon Pharma (0 Trials) |
|
| E-52862 / Mundipharma, Purdue (0 Trials) |
|
| E-58425 / Purdue, Mundipharma, Esteve (1 Trials) |
|
| E-602 / Palleon Pharma (0 Trials) |
|
| E-GT-04 / ENovate Biolife (0 Trials) |
|
| E-PCP-04 / ENovate Biolife (0 Trials) |
|
| E-US-02 / ENovate Biolife (0 Trials) |
|
| E14 / Altay Therap (0 Trials) |
|
| E2012 / Eisai (0 Trials) |
|
| E2025 / Eisai (0 Trials) |
|
| E2082 / Eisai (0 Trials) |
|
| E2307 / Eisai (0 Trials) |
|
| E2511 / Eisai (0 Trials) |
|
| E2730 / Eisai (0 Trials) |
|
| E2814 / Eisai, University College London (0 Trials) |
|
| E478 stem cell gene therapy / Magenta Therap (0 Trials) |
|
| E6 TCR / Gilead (0 Trials) |
|
| E6130 / Eisai (0 Trials) |
|
| E6201 / Strategia Therap (1 Trials) |
|
| E6742 / Eisai (0 Trials) |
|
| E7 TCR cells / National Cancer Institute, Gilead (0 Trials) |
|
| E7 TCR-T / Rutgers University (0 Trials) |
|
| E7016 / Eisai (0 Trials) |
|
| E7107 / Eisai (0 Trials) |
|
| E7130 / Eisai (0 Trials) |
|
| E7766 / Eisai (0 Trials) |
|
| E7820 / Eisai (1 Trials) |
|
| E8001 / Eisai (0 Trials) |
|
| EA-230 / Exponential Biotherapies (0 Trials) |
|
| EA-2353 / endogena (0 Trials) |
|
| EA1080 / Eisai (0 Trials) |
|
| EA3571 / Eisai (0 Trials) |
|
| EA4017 / Eisai (0 Trials) |
|
| Easyef (nepidermin) / Daewoong Pharma (0 Trials) |
|
| Easyfive-TT (fully liquid pentavalent vaccine DTwP-HepB-Hib) / Panacea Biotec (0 Trials) |
|
| Easyhaler tiotropium (tiotropium bromide) / Orion Corp (0 Trials) |
|
| EB-101 / Abeona Therap (0 Trials) |
|
| EB-203 / EyebioKorea (0 Trials) |
|
| EB01 / Edesa Biotech (0 Trials) |
|
| EB05 / Edesa Biotech, Light Chain Biosci (0 Trials) |
|
| EB06 / Light Chain Biosci, Edesa Biotech (0 Trials) |
|
| EB1003 (ipilimumab biosimilar) / Eden Biologics (0 Trials) |
|
| EB1004 (ustekinumab biosimilar) / Eden Biologics (0 Trials) |
|
| EB1010 / Enterome, Nestle (0 Trials) |
|
| EB110 / Enterome, J&J (0 Trials) |
|
| EB120 / Enterome, Takeda (0 Trials) |
|
| EB160 / Shanghai Euregen Biopharma (0 Trials) |
|
| EB220 / Enterome (0 Trials) |
|
| EB410 / Enterome, Takeda (0 Trials) |
|
| EB420 / Enterome, Takeda (0 Trials) |
|
| ebastine / Generic mfg. (5 Trials) |
|
| EBC-129 / A*Star, National Cancer Centre Singapore (0 Trials) |
|
| ebdarokimab (AK101) / Akesobio (0 Trials) |
|
| EBI-001 / Emergent Biosolutions (0 Trials) |
|
| EBI-018 / CARISMA Therap (0 Trials) |
|
| EBI-031 / CARISMA Therap (0 Trials) |
|
| EBI-1041 / Jiangsu Hengrui Medicine (0 Trials) |
|
| EBI-1051 / Jiangsu Hengrui Pharma (0 Trials) |
|
| EBI-1367 / Jiangsu Hengrui Pharma (0 Trials) |
|
| EBI-600215 / Jiangsu Hengrui Pharma (0 Trials) |
|
| EBI-907 / Jiangsu Hengrui Pharma (0 Trials) |
|
| EBI-945 / Jiangsu Hengrui Pharma (0 Trials) |
|
| EBI-cpdX / Jiangsu Hengrui Pharma (0 Trials) |
|
| eblasakimab (ASLAN004) / ASLAN Pharma (2 Trials) |
|
| ebopiprant (OBE022) / Organon, ObsEva (0 Trials) |
|
| EBP921 / Eiger, AstraZeneca (0 Trials) |
|
| EBRGD / Molecular Targeting Tech (0 Trials) |
|
| ebronucimab (AK102) / Akesobio (0 Trials) |
|
| EBS-Lassa / Emergent Biosolutions (0 Trials) |
|
| EBS-Marburg / Emergent Biosolutions (0 Trials) |
|
| EBS-Sudan / Emergent Biosolutions (0 Trials) |
|
| ebselen (SPI-1005) / Sound Pharma (5 Trials) |
|
| EBT-107 / Excision BioTherap (0 Trials) |
|
| EBTATE / Molecular Targeting Tech (0 Trials) |
|
| EBV GP350 CAR-T-cell therapy / Fudan University (0 Trials) |
|
| EBV gp350-Ferritin vaccine / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| EBV LMP2A TCR-T-cell therapy / Fudan University (0 Trials) |
|
| EBV TCR T cell therapy / China Immunotech (0 Trials) |
|
| EBV-specific anti-PD1Â TCR-TÂ cells / TCRCure (0 Trials) |
|
| ebvaciclib (PF-06873600) / Pfizer (0 Trials) |
|
| EBX-002 / Spexis (0 Trials) |
|
| EBX-205 / Emergent Biosolutions (0 Trials) |
|
| EC-372 / Evestra (0 Trials) |
|
| EC-70124 / EntreChem (0 Trials) |
|
| EC0489 / Novartis (0 Trials) |
|
| EC0492 / Novartis (0 Trials) |
|
| EC1169 / Novartis (0 Trials) |
|
| EC1788 / Novartis (0 Trials) |
|
| EC2629 / Novartis (0 Trials) |
|
| EC313 / Evestra (0 Trials) |
|
| EC359 / Evestra (0 Trials) |
|
| EC5026 / EicOsis (0 Trials) |
|
| ECC0509 / Eccogene (0 Trials) |
|
| ECC4703 / Eccogene (0 Trials) |
|
| ECC5004 / Eccogene (0 Trials) |
|
| Ecclock (sofpironium bromide) / Brickell, Kaken Pharma (3 Trials) |
|
| eCD4-Ig / Emmune (0 Trials) |
|
| echinomycin / Merck (MSD) (0 Trials) |
|
| EchoSeed (iodine-125) / GE Healthcare (0 Trials) |
|
| ECI-006 / eTheRNA immunotherapies (0 Trials) |
|
| ECI301 / Effector Cell Institute (0 Trials) |
|
| ecleralimab (CSJ117) / Novartis, MorphoSys (0 Trials) |
|
| eclitasertib (DNL758) / Denali Therap, Sanofi (0 Trials) |
|
| ecnoglutide (XW004) / Sciwind Biosci (0 Trials) |
|
| EcoActive / Intralytix (0 Trials) |
|
| ecopipam (PSYRX 101) / Paragon Biosci (0 Trials) |
|
| ecopladib (PLA-025) / Pfizer (0 Trials) |
|
| ecothiopate iodide (MI 100) / Makindus (1 Trials) |
|
| ecraprost (AS-013) / LTT Bio-Pharma (0 Trials) |
|
| ecromeximab (KM-871) / Life Science Pharma (0 Trials) |
|
| ECT-001-CB / ExCellThera (0 Trials) |
|
| ECT204 / Eureka Therap (0 Trials) |
|
| ecubectedin (PM14) / PharmaMar (0 Trials) |
|
| eculizumab biosimilar / Turgut Pharma (0 Trials) |
|
| eculizumab biosimilar / CinnaGen (0 Trials) |
|
| EDACS-based opioid analgesic / Akela (0 Trials) |
|
| edaravone / Generic mfg. (0 Trials) |
|
| edaravone oral (FNP122) / Treeway, Ferrer International (0 Trials) |
|
| edasalonexent (CAT-1004) / Astria Therap (0 Trials) |
|
| edatrexate (CGP-30694) / Memorial Sloan-Kettering Cancer Center, SRI International (0 Trials) |
|
| EDC9 / Centrose (0 Trials) |
|
| EDDC-2214 / Everest Medicines (0 Trials) |
|
| edecesertib (GS-5718) / Gilead (0 Trials) |
|
| EDG-001 / Edgewise Therap (0 Trials) |
|
| EDG-002 / Edgewise Therap (0 Trials) |
|
| EDG-5506 / Edgewise Therap (0 Trials) |
|
| Edge-P Plus (evening primrose oil/methylcobalamin) / Elder Pharma (0 Trials) |
|
| EDI048 / Novartis (0 Trials) |
|
| edicotinib (PRV-6527) / Provention Bio (2 Trials) |
|
| Edirol (eldecalcitol) / Roche, Taisho (3 Trials) |
|
| EDIT-102 / AbbVie, Editas Medicine (0 Trials) |
|
| EDIT-201 / Editas Medicine (0 Trials) |
|
| EDIT-202 / Bayer, Shoreline Biosci (0 Trials) |
|
| EDIT-301 / Editas Medicine (0 Trials) |
|
| edivoxetine (LY2216684) / Eli Lilly (0 Trials) |
|
| EDO-772P / Mundipharma (0 Trials) |
|
| edonerpic (T-817MA) / Fujifilm Holdings (1 Trials) |
|
| EDP-235 / Enanta Pharma (0 Trials) |
|
| EDP-239 / Enanta (0 Trials) |
|
| EDP-297 / Enanta Pharma (0 Trials) |
|
| EDP-305 / Enanta (2 Trials) |
|
| EDP-32 / BioLineRx (0 Trials) |
|
| EDP-323 / Enanta Pharma (0 Trials) |
|
| EDP-494 / Enanta (0 Trials) |
|
| EDP-546 / Enanta (0 Trials) |
|
| EDP-721 / Enanta Pharma (0 Trials) |
|
| EDP-788 / Enanta (0 Trials) |
|
| EDP-938 / Enanta Pharma (0 Trials) |
|
| EDP1066 / Evelo Biosci (0 Trials) |
|
| EDP1503 / Evelo Biosci (0 Trials) |
|
| EDP1815 / Evelo Biosci (0 Trials) |
|
| EDP1867 / Evelo Biosci (0 Trials) |
|
| EDP1908 / Evelo Biosci (0 Trials) |
|
| EDP2939 / Evelo Biosci (0 Trials) |
|
| EDP514 / Enanta Pharma (0 Trials) |
|
| edralbrutinib (TG-1701) / TG Therap (0 Trials) |
|
| edratide (hCDR1) / XTL Biopharma (0 Trials) |
|
| Edsivo (celiprolol) / Acer Therap (0 Trials) |
|
| Edurant (rilpivirine) / J&J (0 Trials) |
|
| EDV-plasmid-spike-GC / EnGeneIC (0 Trials) |
|
| EdX-17 / EpimedX (0 Trials) |
|
| EF-009 / Everfront Biotech (0 Trials) |
|
| EF005 / Everfront Biotech (0 Trials) |
|
| efatutazone (CS-7017) / Daiichi Sankyo (2 Trials) |
|
| efavaleukin alfa (AMG 592) / Amgen (0 Trials) |
|
| efavirenz / Generic mfg. (0 Trials) |
|
| efavirenz/emtricitabine/tenofovir disoproxil fumarate / Generic mfg. (11 Trials) |
|
| efdamrofusp alfa (IBI302) / Innovent Biologics (3 Trials) |
|
| Efdinir (cefdinir) / Incepta (0 Trials) |
|
| Effirma (flupirtine) / Synthetic Biologics, Mylan (0 Trials) |
|
| efgartigimod SC (ARGX-113 SC) / argenx (1 Trials) |
|
| efgivanermin alfa (MEDI1873) / AstraZeneca (0 Trials) |
|
| efizonerimod (MEDI6383) / AgonOx, AstraZeneca (0 Trials) |
|
| Efleira (netakimab) / Biocad (3 Trials) |
|
| eflepedocokin alfa (F-652) / Yifan Pharma (2 Trials) |
|
| eflornithine / Orbus Therap (0 Trials) |
|
| eflornithine topical / Generic mfg. (0 Trials) |
|
| efmarodocokin alfa (RG7880) / Roche (0 Trials) |
|
| efmitermant alfa (ACE-083) / Merck (MSD) (0 Trials) |
|
| efocipegtrutide (HM15211) / Hanmi (0 Trials) |
|
| efpeglenatide (HM11260C) / Sanofi (0 Trials) |
|
| efpegsomatropin (HM10560A) / Hanmi (0 Trials) |
|
| efruxifermin (AKR-001) / Amgen (0 Trials) |
|
| eftansomatropin alfa (GX-H9) / Genexine (1 Trials) |
|
| eftozanermin alfa (ABBV-621) / AbbVie, Apogenix (0 Trials) |
|
| EG-007 / Evergreen Therap (0 Trials) |
|
| EG-011 / E2DG, Oncology Institute of Southern Switzerland (0 Trials) |
|
| EG-02 / enGene (0 Trials) |
|
| EG-10 / enGene (0 Trials) |
|
| EG-12 / J&J (0 Trials) |
|
| EG-HPCP-03a / Evergreen Therap (0 Trials) |
|
| EG-HZ vaccine / Eyegene (0 Trials) |
|
| EG014 / Premier Veterinary (0 Trials) |
|
| EG12021 (bevacizumab biosimilar) / EirGenix (0 Trials) |
|
| EG1206A (pertuzumab biosimilar) / EirGenix (0 Trials) |
|
| Egalet-003 / Assertio (0 Trials) |
|
| eganelisib (IPI-549) / Infinity Pharma (5 Trials) |
|
| egaptivon pegol (ARC1779) / Archemix (0 Trials) |
|
| EGFR based B cell immunotherapy / Imugene (0 Trials) |
|
|